Search results
Results from the WOW.Com Content Network
Sigma-Aldrich (formally MilliporeSigma) [5] [6] is an American chemical, life science, and biotechnology company owned by the multinational chemical conglomerate Merck Group. Sigma-Aldrich was created in 1975 by the merger of Sigma Chemical Company and Aldrich Chemical Company.
In 1891, Georg(e) Merck established himself in the United States and set up Merck & Co. with Theodore Weicker in New York. Merck & Co. was confiscated following the First World War and set up as an independent company in the United States. [14] [15] Today, the US company, which operates as Merck Sharp and Dohme (MSD) outside the U.S. and Canada ...
Merck is a supplier to the life science industry. The Millipore Corporation was founded in 1954, and listed among the S&P 500 since the early 1990s, as an international biosciences company which makes micrometer pore-size filters and tests. In 2015, Merck acquired Sigma-Aldrich and merged it with Merck Millipore.
Merck & Co. traces its origins to its former German parent company Merck Group, which was established by the Merck family in 1668 when Friedrich Jacob Merck purchased a drug store in Darmstadt. [ 27 ] [ 28 ] In 1827, Merck Group evolved from a pharmacy to a drug manufacturer company with the commercial manufacture of morphine . [ 29 ]
Millipore Corporation, a biosciences company acquired by Merck Group in 2010 MilliporeSigma , former name of Sigma-Aldrich Merck Millipore , deprecated brand name used by Merck Group after Millipore acquisition
For premium support please call: 800-290-4726 more ways to reach us
Coat of arms of the Darmstadt branch of the Merck family Coat of arms of the Hamburg branch of the Merck family Engel-Apotheke. The Merck family is a German noble family of industrialists and bankers, known for establishing the world's oldest pharmaceutical company Merck, its American former subsidiary Merck & Co. (MSD), which is now an independent company, as well as the Hamburg merchant bank ...
From December 2011 to December 2012, if you bought shares in companies when Helen H. Hobbs, M.D. joined the board, and sold them when she left, you would have a 23.0 percent return on your investment, compared to a 15.3 percent return from the S&P 500.